B0084-112349
Scientist.com Supplier
Myrcludex B
BOC Sciences
DESCRIPTION
Myrcludex B is a drug candidate for the treatment of hepatitis B and D. It is under a phase II clinical trial. Myrcludex B acts by inhibiting the sodium taurocholate cotransporting polypeptide.
DETAILS
- Aliases: MyrB; Myrcludex-B; Hepatera; MYR Pharma; Vision7; Bulevirtide
- Cas Number: 2012558-47-1
- Molecular Weight: 5398.95
- Molecular Formula: C248H355N65O72